FDA Expands Uzedy Indication to Bipolar I Disorder

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I disorder in adults.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-expands-uzedy-indication-bipolar-i-disorder-2025a1000rk1?src=rss

Author :

Publish date : 2025-10-13 16:48:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

FDA Expands Uzedy Indication to Bipolar I Disorder

AI in Sleep: Leveraging Wearables While Avoiding Legal Pitfalls

How Do GLP-1 Drugs Stack Up for Cardiorenal Benefits in Diabetes?

Related Posts

Do High-Fat Dairy Products Protect the Brain?

Pediatricians Fault Australia’s Social Media Ban for Teens

FDA OKs Subcutaneous Amivantamab for EGFR-Mutated NSCLC

Amyloid Testing Shows Minimal Effect on Lifestyle Changes

Smartwatches Help Parents Curb Kids’ Tantrums

Mobile Tools Aid Weight Loss and Liver Wellness in NAFLD

Do High-Fat Dairy Products Protect the Brain?

Pediatricians Fault Australia’s Social Media Ban for Teens

FDA OKs Subcutaneous Amivantamab for EGFR-Mutated NSCLC

Amyloid Testing Shows Minimal Effect on Lifestyle Changes

Smartwatches Help Parents Curb Kids’ Tantrums

Mobile Tools Aid Weight Loss and Liver Wellness in NAFLD

Roman soldiers defending Hadrian’s Wall had intestinal parasites

How to Improve the Health Payment System? Experts Count the Ways at Senate Hearing.

Categories

Archives